Veterans Affairs banner with U.S. Flag

VA National Clinical Public Health Programs — HIV/AIDS

www.hiv.va.gov

Send to printer
< Close window

Disclaimer: This information is not meant to substitute for professional advice; please consult your medical provider or pharmacist.

Drug Dosing Toolkit

Rescriptor (delavirdine)

Type of Drug: Nonnucleoside Reverse Transcriptase Inhibitor
(NNRTI, nonnucleoside, "nonnuke")

Approved adult dosing

four 100 mg tablets, three times a day

  • Morning

    Rescriptor 100Rescriptor 100Rescriptor 100Rescriptor 100

    Rescriptor 100 mg

  • Mid-day

    Rescriptor 100Rescriptor 100Rescriptor 100Rescriptor 100

    Rescriptor 100 mg

  • Evening

    Rescriptor 100Rescriptor 100Rescriptor 100Rescriptor 100

    Rescriptor 100 mg

two 200 mg tablets, three times a day

  • Morning

    Rescriptor 200Rescriptor 200

    Rescriptor 200 mg

  • Mid-day

    Rescriptor 200Rescriptor 200

    Rescriptor 200 mg

  • Evening

    Rescriptor 200Rescriptor 200

    Rescriptor 200 mg

My doctor's instructions

Notes on taking this medication

  • No food restrictions, can take with or without food
  • Rescriptor interacts with many other drugs; persons using Rescriptor with those drugs may need an adjustment to their dose of Rescriptor or the other drugs; consult your medical provider

Side effects

  • Rash (usually occurs within first 3 weeks of starting drug)
  • Liver inflammation and increased liver enzyme levels
  • Headache; fatigue; stomach upset
^ Back to the topProviders' HomePatients' Home